The "Bladder Cancer Diagnostics Market by Test Type, by Stages, by Cancer Type, by End User, and By Region" report has been ...

According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...

Taking a combination of two drugs including statins could lower cholesterol - and slow the progression of a common cancer, ...

Climate change is increasing the risk of urological diseases, including cancer and kidney conditions, while urological ...

Cancer is a leading cause of mortality worldwide, and men above 40 are particularly at risk for certain types. While several ...

Shiva Rajkumar, who last month underwent bladder cancer surgery in the US, is back in his hometown of Bengaluru, where he met with fans and colleagues who were extremely happy to see him healthy.

KRISTOPHER WENTZEL ONCOLOGY Hematologist Oncologist The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate Dr. Kristopher Wentzel leads the ...

The preeminent expert on the two-century history of what's now known as Albany Academies, McClintock spent decades ...

Sequential gemcitabine docetaxel is increasingly viewed as a valid option for BCG unresponsive non-muscle-invasive bladder cancer (NMIBC).

Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) ...

CARLSBAD, Calif. - Tyra Biosciences , Inc. (NASDAQ:TYRA), a biotech firm specializing in precision medicines targeting Fibroblast Growth Factor Receptor (FGFR) biology, today announced the appointment ...

"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...